Ocular drug delivery system (ODDS) is a dosage form, vehicle, or system intended for instilling, administering, or delivering drug/medicine to eye against any ailment or disorder involving or affecting vision. It ranges from simple sterile eye drop for the ocular surface to complex implants for intraocular tissue.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Ocular Drug Delivery industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Topical
Ocular Inserts
Iontophoresis
Intraocular Implants
Market Segment by Product Application
Hospitals
Ambulatory Surgical Centers
Ophthalmic Clinics
Homecare Settings
Finally, the report provides detailed profile and data information analysis of leading company.
OCULAR THERAPEUTIX, INC
Alimera Sciences
Allergan, Plc
EyeGate Pharma
Valeant Pharmaceuticals International, Inc
Envisia Therapeutics
Clearside Biomedical
Graybug Vision Inc
Taiwan Liposome Company
Santen Pharmaceutical
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Ocular Drug Delivery consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Ocular Drug Delivery market by identifying its various subsegments.
3.Focuses on the key global Ocular Drug Delivery manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Ocular Drug Delivery with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Ocular Drug Delivery submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Ocular Drug Delivery Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Ocular Drug Delivery Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Ocular Drug Delivery Segment by Type
2.1.1 Topical
2.1.2 Ocular Inserts
2.1.3 Iontophoresis
2.1.4 Intraocular Implants
2.2 Market Analysis by Application
2.2.1 Hospitals
2.2.2 Ambulatory Surgical Centers
2.2.3 Ophthalmic Clinics
2.2.4 Homecare Settings
2.3 Global Ocular Drug Delivery Market Comparison by Regions (2017-2027)
2.3.1 Global Ocular Drug Delivery Market Size (2017-2027)
2.3.2 North America Ocular Drug Delivery Status and Prospect (2017-2027)
2.3.3 Europe Ocular Drug Delivery Status and Prospect (2017-2027)
2.3.4 China Ocular Drug Delivery Status and Prospect (2017-2027)
2.3.5 Japan Ocular Drug Delivery Status and Prospect (2017-2027)
2.3.6 Southeast Asia Ocular Drug Delivery Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Ocular Drug Delivery Industry Impact
2.5.1 Ocular Drug Delivery Business Impact Assessment - Covid-19
2.5.2 Market Trends and Ocular Drug Delivery Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Ocular Drug Delivery Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Ocular Drug Delivery Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Ocular Drug Delivery Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Ocular Drug Delivery Manufacturer Market Share
3.5 Top 10 Ocular Drug Delivery Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Ocular Drug Delivery Market
3.7 Key Manufacturers Ocular Drug Delivery Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Ocular Drug Delivery Industry Key Manufacturers
4.1 OCULAR THERAPEUTIX, INC
4.1.1 Compan Detail
4.1.2 OCULAR THERAPEUTIX, INC Ocular Drug Delivery Product Introduction, Application and Specification
4.1.3 OCULAR THERAPEUTIX, INC 139 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 OCULAR THERAPEUTIX, INC News
4.2 Alimera Sciences
4.2.1 Compan Detail
4.2.2 Alimera Sciences Ocular Drug Delivery Product Introduction, Application and Specification
4.2.3 Alimera Sciences Ocular Drug Delivery Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 OCULAR THERAPEUTIX, INC News
4.3 Allergan, Plc
4.3.1 Compan Detail
4.3.2 Allergan, Plc Ocular Drug Delivery Product Introduction, Application and Specification
4.3.3 Allergan, Plc Ocular Drug Delivery Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Allergan, Plc News
4.4 EyeGate Pharma
4.4.1 Compan Detail
4.4.2 EyeGate Pharma Ocular Drug Delivery Product Introduction, Application and Specification
4.4.3 EyeGate Pharma Ocular Drug Delivery Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 EyeGate Pharma News
4.5 Valeant Pharmaceuticals International, Inc
4.5.1 Compan Detail
4.5.2 EyeGate Pharma Ocular Drug Delivery Product Introduction, Application and Specification
4.5.3 Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Valeant Pharmaceuticals International, Inc News
4.6 Envisia Therapeutics
4.6.1 Compan Detail
4.6.2 Envisia Therapeutics Ocular Drug Delivery Product Introduction, Application and Specification
4.6.3 Envisia Therapeutics Ocular Drug Delivery Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Envisia Therapeutics News
4.7 Clearside Biomedical
4.7.1 Compan Detail
4.7.2 Clearside Biomedical Ocular Drug Delivery Product Introduction, Application and Specification
4.7.3 Clearside Biomedical Ocular Drug Delivery Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Graybug Vision Inc
4.8.1 Compan Detail
4.8.2 Graybug Vision Inc Ocular Drug Delivery Product Introduction, Application and Specification
4.8.3 Graybug Vision Inc Ocular Drug Delivery Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Graybug Vision Inc News
4.9 Taiwan Liposome Company
4.9.1 Compan Detail
4.9.2 Taiwan Liposome Company Ocular Drug Delivery Product Introduction, Application and Specification
4.9.3 Taiwan Liposome Company Ocular Drug Delivery Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Taiwan Liposome Company News
4.10 Santen Pharmaceutical
4.10.1 Compan Detail
4.10.2 Santen Pharmaceutical Ocular Drug Delivery Product Introduction, Application and Specification
4.10.3 Santen Pharmaceutical Ocular Drug Delivery Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 Santen Pharmaceutical News
5 Global Ocular Drug Delivery Market Segment by Big Type
5.1 Global Ocular Drug Delivery Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Ocular Drug Delivery Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Ocular Drug Delivery Revenue and Market Share by Big Type (2017-2022)
5.2 Topical Sales Growth Rate and Price
5.2.1 Global Topical Sales Growth Rate (2017-2022)
5.2.2 Global Topical Price (2017-2022)
5.3 Ocular Inserts Sales Growth Rate and Price
5.3.1 Global Ocular Inserts Sales Growth Rate (2017-2022)
5.3.2 Global Ocular Inserts Price (2017-2022)
5.4 Iontophoresis Sales Growth Rate and Price
5.4.1 Global Iontophoresis Sales Growth Rate (2017-2022)
5.4.2 Global Iontophoresis Price (2017-2022)
5.5 Intraocular Implants Sales Growth Rate and Price
5.5.1 Global Intraocular Implants Sales Growth Rate (2017-2022)
5.5.2 Global Intraocular Implants Price (2017-2022)
6 Global Ocular Drug Delivery Market Segment by Big Application
6.1 Global Ocular Drug Delivery Sales Market Share by Big Application (2017-2022)
6.2 Hospitals Sales Growth Rate (2017-2022)
6.3 Ambulatory Surgical Centers Sales Growth Rate (2017-2022)
6.4 Ophthalmic Clinics Sales Growth Rate (2017-2022)
6.5 Homecare Settings Sales Growth Rate (2017-2022)
7 Global Ocular Drug Delivery Forecast
7.1 Global Ocular Drug Delivery Revenue, Sales and Growth Rate (2022-2027)
7.2 Ocular Drug Delivery Market Forecast by Regions (2022-2027)
7.2.1 North America Ocular Drug Delivery Market Forecast (2022-2027)
7.2.2 Europe Ocular Drug Delivery Market Forecast (2022-2027)
7.2.3 China Ocular Drug Delivery Market Forecast (2022-2027)
7.2.4 Japan Ocular Drug Delivery Market Forecast (2022-2027)
7.2.5 Southeast Asia Ocular Drug Delivery Market Forecast (2022-2027)
7.2.6 Other Regions Ocular Drug Delivery Market Forecast (2022-2027)
7.3 Ocular Drug Delivery Market Forecast by Type (2022-2027)
7.3.1 Global Ocular Drug Delivery Sales Forecast by Type (2022-2027)
7.3.2 Global Ocular Drug Delivery Market Share Forecast by Type (2022-2027)
7.4 Ocular Drug Delivery Market Forecast by Application (2022-2027)
7.4.1 Global Ocular Drug Delivery Sales Forecast by Application (2022-2027)
7.4.2 Global Ocular Drug Delivery Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Ocular Drug Delivery Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Ocular Drug Delivery Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Ocular Drug Delivery
Figure Market Concentration Ratio and Market Maturity Analysis of Ocular Drug Delivery
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Ocular Drug Delivery Market Size by Big Type
Figure Global Market Share of Ocular Drug Delivery by Big Type in 2021
Figure Topical Picture (2017-2022)
Figure Ocular Inserts Picture (2017-2022)
Figure Iontophoresis Picture (2017-2022)
Global Ocular Drug Delivery Market Size by Big Application
Table Global Ocular Drug Delivery Market Size by Application
Figure Global Ocular Drug Delivery Market Share by Big Application in 2021
Figure Hospitals Picture
Figure Ambulatory Surgical Centers Picture
Figure Ophthalmic Clinics Picture
Figure Homecare Settings Picture
Table Global Ocular Drug Delivery Comparison by Regions (M USD) (2017-2027)
Figure Global Ocular Drug Delivery Market Size (Million US$) (2017-2027)
Figure North America Ocular Drug Delivery Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Ocular Drug Delivery Revenue (Million US$) Growth Rate (2017-2027)
Figure China Ocular Drug Delivery Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Ocular Drug Delivery Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Ocular Drug Delivery Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Ocular Drug Delivery Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Ocular Drug Delivery Sales by Manufacturer (2017-2022)
Figure Global Ocular Drug Delivery Sales Market Share by Manufacturer in 2021
Table Global Ocular Drug Delivery Revenue by Manufacturer (2017-2022)
Figure Global Ocular Drug Delivery Revenue Market Share by Manufacturer in 2021
Table Global Ocular Drug Delivery Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Ocular Drug Delivery Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Ocular Drug Delivery Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Ocular Drug Delivery Market
Table Key Manufacturers Ocular Drug Delivery Product Type
Table Mergers & Acquisitions Planning
Table OCULAR THERAPEUTIX, INC Company Profile
Table Ocular Drug Delivery Product Introduction, Application and Specification of OCULAR THERAPEUTIX, INC
Table Ocular Drug Delivery Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Alimera Sciences Company Profile
Table Ocular Drug Delivery Product Introduction, Application and Specification of Alimera Sciences
Table Ocular Drug Delivery Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Alimera Sciences Recent Development
Table Allergan, Plc Company Profile
Table Ocular Drug Delivery Product Introduction, Application and Specification of Allergan, Plc
Table Ocular Drug Delivery Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Allergan, Plc Main Business
Table Allergan, Plc Recent Development
Table EyeGate Pharma Company Profile
Table Ocular Drug Delivery Product Introduction, Application and Specification of EyeGate Pharma
Table Ocular Drug Delivery Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table EyeGate Pharma Main Business
Table EyeGate Pharma Recent Development
Table EyeGate Pharma Main Business
Table EyeGate Pharma Recent Development
Table Valeant Pharmaceuticals International, Inc Company Profile
Table Ocular Drug Delivery Product Introduction, Application and Specification of Valeant Pharmaceuticals International, Inc
Table Ocular Drug Delivery Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Valeant Pharmaceuticals International, Inc Main Business
Table Valeant Pharmaceuticals International, Inc Recent Development
Table Envisia Therapeutics Company Profile
Table Ocular Drug Delivery Product Introduction, Application and Specification of Envisia Therapeutics
Table Ocular Drug Delivery Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Envisia Therapeutics Main Business
Table Envisia Therapeutics Recent Development
Table Clearside Biomedical Company Profile
Table Ocular Drug Delivery Product Introduction, Application and Specification of Clearside Biomedical
Table Ocular Drug Delivery Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Clearside Biomedical Main Business
Table Clearside Biomedical Recent Development
Table Graybug Vision Inc Company Profile
Table Ocular Drug Delivery Product Introduction, Application and Specification of Graybug Vision Inc
Table Ocular Drug Delivery Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Graybug Vision Inc Main Business
Table Graybug Vision Inc Recent Development
Table Taiwan Liposome Company Company Profile
Table Ocular Drug Delivery Product Introduction, Application and Specification of Taiwan Liposome Company
Table Ocular Drug Delivery Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Taiwan Liposome Company Main Business
Table Taiwan Liposome Company Recent Development
Table Santen Pharmaceutical Company Profile
Table Ocular Drug Delivery Product Introduction, Application and Specification of Santen Pharmaceutical
Table Ocular Drug Delivery Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Santen Pharmaceutical Main Business
Table Santen Pharmaceutical Recent Development
Figure Global Ocular Drug Delivery Sales and Growth Rate (2017-2022)
Figure Global Ocular Drug Delivery Revenue and Growth Rate (2017-2022)
Table Global Ocular Drug Delivery Sales by Regions (2017-2022)
Figure Global Ocular Drug Delivery Sales Market Share by Regions in 2021
Table Global Ocular Drug Delivery Revenue by Regions (2017-2022)
Figure Global Ocular Drug Delivery Revenue Market Share by Regions in 2021
Figure North America Ocular Drug Delivery Sales and Growth Rate (2017-2022)
Figure Europe Ocular Drug Delivery Sales and Growth Rate (2017-2022)
Figure China Ocular Drug Delivery Sales and Growth Rate (2017-2022)
Figure Japan Ocular Drug Delivery Sales and Growth Rate (2017-2022)
Figure Southeast Asia Ocular Drug Delivery Sales and Growth Rate (2017-2022)
Figure Other Regions Ocular Drug Delivery Sales and Growth Rate (2017-2022)
Table Global Ocular Drug Delivery Sales by Big Type (2017-2022)
Table Global Ocular Drug Delivery Sales Market Share by Big Type (2017-2022)
Figure Global Ocular Drug Delivery Sales Market Share by Big Type in 2019
Table Global Ocular Drug Delivery Revenue by Big Type (2017-2022)
Table Global Ocular Drug Delivery Revenue Market Share by Big Type (2017-2022)
Table Global Ocular Drug Delivery Revenue Market Share by Big Type in 2019
Figure Global Topical Sales Growth Rate (2017-2022)
Figure Global Topical Price (2017-2022)
Figure Global Ocular Inserts Sales Growth Rate (2017-2022)
Figure Global Ocular Inserts Price (2017-2022)
Figure Global Iontophoresis Sales Growth Rate (2017-2022)
Figure Global Iontophoresis Price (2017-2022)
Figure Global Intraocular Implants Sales Growth Rate (2017-2022)
Table Global Ocular Drug Delivery Sales by Big Application (2017-2022)
Table Global Ocular Drug Delivery Sales Market Share by Big Application (2017-2022)
Figure Global Ocular Drug Delivery Sales Market Share by Big Application in 2019
Figure Global Hospitals Sales Growth Rate (2017-2022)
Figure Global Ambulatory Surgical Centers Sales Growth Rate (2017-2022)
Figure Global Ophthalmic Clinics Sales Growth Rate (2017-2022)
Figure Global Homecare Settings Sales Growth Rate (2017-2022)
Figure Global Ocular Drug Delivery Sales and Growth Rate (2022-2027)
Figure Global Ocular Drug Delivery Revenue and Growth Rate (2022-2027)
Table Global Ocular Drug Delivery Sales Forecast by Regions (2022-2027)
Table Global Ocular Drug Delivery Market Share Forecast by Regions (2022-2027)
Figure North America Sales Ocular Drug Delivery Market Forecast (2022-2027)
Figure Europe Sales Ocular Drug Delivery Market Forecast (2022-2027)
Figure China Sales Ocular Drug Delivery Market Forecast (2022-2027)
Figure Japan Sales Ocular Drug Delivery Market Forecast (2022-2027)
Figure Southeast Asia Sales Ocular Drug Delivery Market Forecast (2022-2027)
Figure Other Regions Sales Ocular Drug Delivery Market Forecast (2022-2027)
Table Global Ocular Drug Delivery Sales Forecast by Type (2022-2027)
Table Global Ocular Drug Delivery Market Share Forecast by Type (2022-2027)
Table Global Ocular Drug Delivery Sales Forecast by Application (2022-2027)
Table Global Ocular Drug Delivery Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Ocular Drug Delivery
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Ocular Drug Delivery Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Ocular Drug Delivery Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Ocular Drug Delivery Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Ocular Drug Delivery Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Ocular Drug Delivery Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Ocular Drug Delivery Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Ocular Drug Delivery Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Ocular Drug Delivery Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
OCULAR THERAPEUTIX, INC
Alimera Sciences
Allergan, Plc
EyeGate Pharma
Valeant Pharmaceuticals International, Inc
Envisia Therapeutics
Clearside Biomedical
Graybug Vision Inc
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)